Announced
Completed
Financials
Tags
United States
peptides developer
agtech
Machinery: Agricultural
Acquisition
Private
Majority
Domestic
Completed
Friendly
Single Bidder
Synopsis
Invaio Sciences, a bio platform company accelerating the leap to nature-positive agriculture, completed the acquisition of Peptyde Bio, a company that discovers, designs and characterizes novel peptides for use in agriculture. Financial terms were not disclosed. “This acquisition adds Peptyde Bio’s portfolio of confirmed peptide lead candidates for use in crop protection to our existing pipeline. When combined with our innovative biological delivery systems, we are uniquely positioned to offer growers more natural, efficient and effective solutions to protect their crops. It’s a truly exciting time for Invaio and the industry as we accelerate the leap to more nature-positive solutions for farmers,” Ignacio Martinez, Invaio Sciences CEO.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.